|
業務類別
|
Biotechnology |
|
業務概覽
|
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methodsused today, such as chemical synthesis, natural extraction, and synthetic biology. |
| 公司地址
| 750 Royal Oaks Drive, Suite 106, Monrovia, CA, USA, 91016 |
| 電話號碼
| +1 626 415-1488 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.exozymes.com |
| 員工數量
| 32 |
| Mr. Damien Perriman |
Chief Commercial Officer |
-- |
30/03/2026 |
| Mr. Michael Heltzen |
President and Chief Executive Officer |
美元 231.25K |
30/03/2026 |
| Mr. Fouad Nawaz |
Vice President, Finance and Principal Accounting Officer |
美元 168.75K |
30/03/2026 |
| Dr. Tyler Korman |
Chief Scientific Officer |
美元 191.22K |
30/03/2026 |
| Dr. Paul Opgenorth |
Vice President, Development |
美元 190.00K |
30/03/2026 |
|
|
| Mr. Christopher A. Marlett |
Chairman of the Board |
30/03/2026 |
| Dr. Lon E. Bell,PhD |
Independent Director |
30/03/2026 |
| Mr. Anthony Digiandomenico |
Independent Director |
30/03/2026 |
| Mr. James J. Lalonde |
Independent Director |
30/03/2026 |
| Mr. Edgardo Rayo |
Director |
30/03/2026 |
| Dr. James U. Bowie, PhD |
Independent Director |
30/03/2026 |
|
|
|
|
